Table 3.
Multivariate analysis of association with time to death.
| Category | Variable | 95% confidence interval |
|||
|---|---|---|---|---|---|
| HR | Lower | Upper | p-Value | ||
| Age at diagnosis | 1-year increase | 1.09 | 1.00 | 1.18 | 0.044 |
| Gender | Male (vs. female) | 13.21 | 0.55 | 315.6 | 0.11 |
| ECOG | 1 or 2 (vs. 0) | 0.98 | 0.26 | 3.66 | 0.97 |
| Smoking status | Current or former smoker (vs. non-smoker) | 0.86 | 0.26 | 2.87 | 0.81 |
| HPV p16 | Negative (vs. positive) | 1.77 | 0.28 | 11.28 | 0.55 |
| Not documented (vs. positive) | 3.36 | 0.84 | 13.43 | 0.087 | |
| Negative (vs. not documented) | 0.53 | 0.07 | 4.02 | 0.54 | |
| BMI at RT start | 1-U increase | 1.20 | 1.04 | 1.38 | 0.012 |
| Percent BMI loss | 1% greater loss | 0.78 | 0.66 | 0.93 | 0.0054 |
| PEG timing | Placed prior to treatment initiation (vs. no) | 11.62 | 1.77 | 76.47 | 0.011 |
| Placed during treatment (vs. no) | 0.43 | 0.08 | 2.24 | 0.32 | |
HR, hazard ratio; RT, radiation therapy; PEG, percutaneous endoscopic gastrostomy tube.